ARTN and pancreatic adenocarcinoma: Emerging evidence indicates that ARTN is involved in the tumorigenesis, tumour metastasis and therapeutic resistance to cancers, such as mammary carcinoma, pancreatic adenocarcinoma and acute myeloid leukaemia.